phosphorylethanolamine has been researched along with Ataxia Telangiectasia Syndrome in 1 studies
phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Perry, TL | 1 |
| Kish, SJ | 1 |
| Hinton, D | 1 |
| Hansen, S | 1 |
| Becker, LE | 1 |
| Gelfand, EW | 1 |
1 other study available for phosphorylethanolamine and Ataxia Telangiectasia Syndrome
| Article | Year |
|---|---|
Neurochemical abnormalities in a patient with ataxia-telangiectasia.
Topics: Ataxia Telangiectasia; Brain; Brain Chemistry; Ethanolamines; gamma-Aminobutyric Acid; Glutamates; H | 1984 |